Quantcast

Latest pharmaceutical industry Stories

2014-09-11 08:28:52

TORONTO, Sept. 11, 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U), announces that it intends to conduct a Private Placement to raise up to US$ 2 million for funding its preclinical development activities and financial commitments to Biohaven Pharmaceutical Holding Company Limited, ("Biohaven"). The Company is proposing to complete a non-brokered offering of up to 20 million common shares at a price of US$0.10...

2014-09-11 04:20:52

DALLAS, September 11, 2014 /PRNewswire/ -- MarketReportsOnline.com adds Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) research report of 194 pages to its store. This research not only provides a comprehensive and thorough knowledge of the latest Chinese regulations for imported medical device registration but also introduces the practical operation on how to comply with the Chinese...

2014-09-10 23:08:02

The Alabama Supreme Court ruled that brand-name drug companies can be sued for injuries caused by its generic equivalent if the brand-name manufacturer made misleading or inaccurate claims about the drug, and those claims were relied upon by the injured person’s physician; this decision confirms the court’s previous ruling last year. Port Washington, New York (PRWEB) September 10, 2014 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by...

2014-09-10 12:29:18

LONDON, ON, Sept. 10, 2014 /CNW/ - "Clinical testing has been one of the biggest barriers to developing new imaging technology for clinical application", says Alvira Macanovic, IP, Regulatory and Clinical Affairs Manager at the Centre for Imaging Technology Commercialization (CIMTEC). "This very important CIMTEC initiative will make it easier for researchers and small and medium-sized companies to achieve a range of goals such as generating clinical data to support pre-market...

2014-09-10 12:28:52

-Dr. Cagnoni Joins Non-Profit Organization Focused on Fostering Innovation and Collaboration to Strengthen the Bay Area BioEconomy- SAN FRANCISCO, Sept. 10, 2014 /PRNewswire/ -- The Bay Area BioEconomy Initiative (BAB) today announced that it has named Pablo J. Cagnoni, M.D., President of Onyx Pharmaceuticals, Inc., to its Steering Committee. Onyx, an Amgen subsidiary, is engaged in the development and commercialization of innovative therapies to improve the lives of people with...

2014-09-10 12:28:37

Major five-year grant with Canadian Consortium on Neurodegeneration in Aging (CCNA) will fund transformative research into disease prevention and treatment MONTREAL, Sept. 10, 2014 /CNW Telbec/ - Sanofi (EURONEXT: SAN and NYSE: SNY) announced today its $2.5 million contribution to co-fund the Canadian Consortium on Neurodegeneration in Aging (CCNA), a partnership officially launched in Montreal today in the presence of The Honourable Rona Ambrose, Minister of Health. With the...

2014-09-10 12:28:22

WASHINGTON, Sept. 10, 2014 /PRNewswire-USNewswire/ -- The following is a statement on behalf of RetireSafe: Dear Member of Congress; We write to you today to bring to your attention a critical safety issue that could affect all Americans, but especially those older Americans who rely on relatively new medicines called "biologics". RetireSafe, a 400,000-supporter strong nationwide advocacy organization for seniors, works hard to give a voice to retired Americans and those who hope to retire....

2014-09-10 12:27:57

NEW YORK, Sept. 10, 2014 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) and OnDeckBiotech announced today the launch of ADDF ACCESS, a new and improved open access platform to connect scientists with a virtual network of contract research organizations (CROs), drug development experts and educational resources. By leveraging OnDeckBiotech's cutting-edge technology, the enhanced ADDF ACCESS platform will streamline links between researchers and CROs specializing...

2014-09-10 12:24:38

AMGEN, ASTRAZENECA AND CELGENE SHOW HIGHEST COMMITMENT TO TRANSPARENCY NEW YORK, Sept. 10, 2014 /PRNewswire/ -- Citeline®, an Informa business unit, and the pharmaceutical industry's leading research authority on clinical trials, reported today that clinical trial transparency, also known as responsible data sharing, is in a much healthier state than shown in previous studies, when you refer to the right variety of sources. http://photos.prnewswire.com/prnvar/20120917/NE75453LOGO...

2014-09-10 12:24:20

Ten-year savings hits record at nearly $1.5 trillion according to annual Generic Drug Savings in the U.S. report WASHINGTON, Sept. 10, 2014 /PRNewswire-USNewswire/ -- The Generic Pharmaceutical Association (GPhA) today released a report showing that generic drugs saved the United States health system $239 billion in 2013, a 14% increase over cost savings achieved in 2012, and the largest annual savings to date. The report also calculates that generic medications saved a record of nearly $1.5...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.